These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. Liu KS; Wong IO; Leung WK World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668 [TBL] [Abstract][Full Text] [Related]
4. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802 [TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680 [TBL] [Abstract][Full Text] [Related]
7. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Chen HN; Wang Z; Li X; Zhou ZG Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452 [TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679 [TBL] [Abstract][Full Text] [Related]
11. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia. Liu D; He Q; Liu C J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study. Bas B; Dinc B Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS; JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144 [TBL] [Abstract][Full Text] [Related]
14. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143 [TBL] [Abstract][Full Text] [Related]
15. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions? Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833 [TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study]. Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions. Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects and benefits of Chen J; Zhang G; Qin J; Huang Y; Wang Y; Li Z; Ji D; Xiao L; Yin S; Bao Z Saudi J Gastroenterol; 2022; 28(2):149-156. PubMed ID: 35083971 [TBL] [Abstract][Full Text] [Related]
20. Risk of gastric cancer in children with Helicobacter pylori infection. Cam S Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]